Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 1, 2011, Pages 123-127

  Drǎgoescu, Octavian ^a   Tomescu, P ^a   Panus A ^a   Enache, M ^a   Maria, C ^a   Stoica, L ^a   Plesea I E ^b  

^a EMERGENCY COUNTY HOSPITAL   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Bladder cancer; Photodynamic diagnosis; Recurrence

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ARTICLE; BLADDER TUMOR; CANCER INVASION; CYSTOSCOPY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIGHT; MALE; METHODOLOGY; MIDDLE AGED; MUSCLE; PATHOLOGY; RECURRENT DISEASE;

AMINOLEVULINIC ACID; CYSTOSCOPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIGHT; MALE; MIDDLE AGED; MUSCLES; NEOPLASM INVASIVENESS; RECURRENCE; URINARY BLADDER NEOPLASMS;

EID: 79953033797     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Boring CC, Squires TS, Tong T, Montgomery S, Cancer statistics, 1994, CA Cancer J Clin, 1994, 44(1):7-26.
2. Tomescu P, Pǎnuş A, Urologie, Ed. Medicalǎ Universitarǎ Craiova, 2006, 119-130.
3. AJCC Cancer Staging Manual. Urinary bladder, 7th edition, Springer, New York, 2010, 497-502.
4. Sinescu I, Glück G, Angelescu E, Tratat de patologie chirurgicalǎ: Tumorile vezicii urinare, Ed. Medicalǎ, Bucureşti, 2001, 2885-2905.
5. European Association of Urology Guidelines 2008, European Association of Urology, 2008.
6. Guney S, Guney N, Canogullari Z, Ergenekon E, Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year, Urol Int, 2008, 80(2):124-128.
7. Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H, Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with nonmuscle- invasive bladder carcinoma, Eur Urol, 2007, 52(4):1123-1129.
8. Schellhammer PF, Immediate adjuvant intravesical chemotherapy after transurethral resection of bladder tumor, Curr Opin Urol, 1998, 8(5):407-409.
9. Kurth KH, Natural history and prognosis of untreated and treated superficial bladder cancer. In: Pagano F, Fair WR (eds), Superficial bladder cancer, Isis Medical Media, Oxford, 1997, 42-56.
10. Kriegmair M, Baumgartner R, Knüchel R, Stepp H, Hofstädter F, Hofstetter A, Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence, J Urol, 1996, 155(1):105-109; discussion 109-110.
11. Zaak D, Kriegmair M, Stepp H, Stepp H, Baumgartner R, Oberneder R, Schneede P, Corvin S, Frimberger D, Knüchel R, Hofstetter A, Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies, Urology, 2001, 57():690- 694.
12. Zaak D, Hungerhuber E, Schneede P, Stepp H, Frimberger D, Corvin S, Schmeller N, Kriegmair M, Hofstetter A, Knuechel R, Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions, Cancer, 2002, 95(6):1234-1238.
13. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds), Pathology and genetics of tumors of the urinary system and male genital organs, World Health Organization Classification of Tumours, IARC Press, Lyon, 2004.
14. Jichlinski P, Guillou L, Karlsen SJ, Malmström PU, Jocham D, Brennhovd B, Johansson E, Gärtner T, Lange N, van den Bergh H, Leisinger HJ, Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer - a multicenter study, J Urol, 2003, 170(1):226-229.
15. Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H, Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer, J Urol, 2001, 165(4):1121-1123.
16. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W, Do patients profit from 5-aminolevulinic acidinduced fluorescence diagnosis in transurethral resection of bladder carcinoma?, Urology, 2002, 60(6):1025-1028.
17. Kriegmair M, Zaak D, Rothenberger KH, Rassweiler J, Jocham D, Eisenberger F, Tauber R, Stenzl A, Hofstetter A, Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy, J Urol, 2002, 168(2):475-478.
18. Filbeck T, Pichlmeier U, Knüchel R, Wieland WF, Rössler W, Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study, Urologe A, 2003, 42(10):1366- 1373.
19. Filbeck T, Rössler W, Knüchel R, Straub M, Kiel HJ, Wieland WF, 5-Aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors, Urology, 1999, 53(1):77-81.